Many recent works have mainly focused on whether RRM1 can be used as a molecular predictor in lung cancer by different methods of biomarker analysis, including quantitative real‐time PCR analysis, immunohistochemistry, western blot analysis, and automated quantitative analysis 7, 20, 21, 22. This evidence concerns the gene RRM1 and lung cancer.